The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Micardis 20 mg tablets

20 milligram(s) Tablet

Boehringer Ingelheim International GmbHEU/1/98/090/009-012

Main Information

Trade NameMicardis 20 mg tablets
Active SubstancesTelmisartan
Strength20 milligram(s)
Dosage FormTablet
Licence HolderBoehringer Ingelheim International GmbH
Licence NumberEU/1/98/090/009-012

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA07 telmisartan

Status

Authorised/WithdrawnAuthorised
Licence Issued07/09/1999
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0049-003-014
Interchangeable List DocumentPDF of Interchangeable List
« Back